OpenAlex
PricingAboutJobs
Log inGet started
Work

Transient Potent BCR-ABL Inhibition Is Sufficient to Commit Chronic Myeloid Leukemia Cells Irreversibly to Apoptosis

HTML PDF

Year: 2008
Type: article
Source: Cancer Cell
DOI: 10.1016/j.ccr.2008.11.001
Authors: Neil P. Shah, Corynn Kasap, Christopher Weier, Minna Balbas, John M. Nicoll, Eric Bleickardt, Claude Nicaise, Charles L. Sawyers
Institutions: University of California, San Francisco, University of California San Francisco Medical Center, Memorial Sloan Kettering Cancer Center, University of California, Los Angeles, Bristol-Myers Squibb (United States), Howard Hughes Medical Institute
Language: English

Topic: Chronic Myeloid Leukemia Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: chronic myeloid leukemia, BCR-ABL, dasatinib, imatinib, apoptosis, Bcl-2, EGFR, erlotinib, lung cancer, dosing regimen, cytotoxicity
SDG: Good health and well-being

Open Access status: bronze

Funders: Howard Hughes Medical Institute, Doris Duke Charitable Foundation
OpenAlex ID: W2093616162
FWCI: 19.56
Cites: 23
Cited by: 240
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms